NASS Updated Spinal Surgery Coverage Guidelines

Healthcare providers must now track new risk-based criteria to secure coverage for rhBMP-2 spinal fusion treatments.

Updated on Oct. 5, 2026 in Healthcare

Bold flat-color editorial illustration of a metallic spinal implant cage against a navy background, symbolizing updated surgical policy guidelines. — The North American Spine Society has updated coverage guidelines for rhBMP-2 spinal fusion, establishing new risk-based criteria for adult patient eligibility. AI Illustration. Upload story photo >

Live Poll

Should medical organizations favor risk-stratified standards over generalized guidelines for complex surgical procedures?

The North American Spine Society (NASS) has revised its coverage recommendations for the use of rhBMP-2 in spinal fusion surgeries. The new guidelines expand eligibility for adult patients identified as having a high risk for nonunion.

Why it matters

The revision aligns clinical standards with data from FDA investigational device exemption studies and a 2013 independent patient data reanalysis. By formalizing these risk factors, the society aims to refine prior authorization workflows for complex spinal procedures.

These updated guidelines replace the standards set in 2014 to better reflect evidence identified in a 2013 independent patient data reanalysis. The update affects the coverage landscape for surgical providers managing complex patient cases.

The players

North American Spine Society

A multidisciplinary medical society that establishes clinical practice guidelines and policy for spine care providers.

The details

Physicians must now document specific metabolic and clinical factors—including smoking, diabetes, hypertension, osteoporosis, and radiation history—to qualify patients for rhBMP-2. These criteria also extend to patients undergoing multilevel surgeries or those with insufficient iliac crest. This documentation is central to shaping updated prior authorization workflows and informing patient consent conversations.

The independent reanalysis of patient data was commissioned in 2013.
The previous rhBMP-2 coverage standards were established in 2014.
NASS announced the revised coverage recommendations on October 5, 2026.

Market Landscape

The new guidelines mark a departure from the 2014 NASS rhBMP-2 coverage standards. This shift integrates longitudinal clinical data into the authorization process for high-risk surgical patients.

Clinical operators should audit their documentation workflows to ensure all metabolic and nonunion risk factors are captured for prior authorization. Practices should review these new criteria with billing departments to ensure claims align with the updated, risk-stratified guidance.

The takeaway

The move formalizes the link between patient risk profiles and treatment access in spinal surgery. Practitioners should integrate these risk markers—such as smoking and diabetes history—into intake documentation to maintain alignment with current coverage standards.